JD Health's stock surged 5.97% during intraday trading on Thursday, reflecting a significant upward movement.

The rally was supported by a broader strengthening in the Hong Kong market, with the Hang Seng Index expanding gains. Positive performance across technology, pharmaceutical, and insurance sectors contributed to the buoyant sentiment. Within the Internet and Direct Marketing Retail sector, peers including Meituan, JD Group, Ali Health, and Alibaba also posted gains, indicating broad-based sector momentum.

Additionally, JD Health's continued share buyback activity signaled management confidence. The company resumed its daily repurchase pace of 500,000 shares, spending approximately 16.39 million HKD, after a brief reduction had previously raised market concerns. This sustained buyback program underscores belief in the company's intrinsic value.